Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma

Conclusion: This application of surface-engineering EVs not only proves the high-performance catalytic therapeutic modality of GE@EVs for HCC, but also broadens the versatile bio-applications of EVs.

Source: Theranostics - January 15, 2021 Category: Molecular Biology Authors: Han Wu, Hao Xing, Meng-Chao Wu, Feng Shen, Yu Chen, Tian Yang Tags: Research Paper Source Type: research